Schedule of assessments—survivors of critical illness
Procedures | Screening | Enrolment | Study visit 1 1 month | Study visit 2 3 months | Pre-visit 3 (within 2 weeks of visit 3) | Final study visit 3 6±1 months |
Informed consent | X | |||||
Demographics | X | |||||
Intensive care unit (ICU) admission history | X | |||||
Mechanical ventilation | X | |||||
Presence/duration of delirium | X | |||||
Presence of tracheostomy | X | |||||
Access to family physician | X | |||||
Randomisation | X | |||||
Height, weight, body mass index | X | X | ||||
Study intervention | X* | X* | ||||
MoCA | X | |||||
CFS | X | |||||
SF-36 | X | |||||
HUI3 | X | X | ||||
HADS | X | |||||
PTSS-14 | X | |||||
CPGS | X | |||||
FSS | X | |||||
Return to work | X | |||||
Katz Index of ADLs | X | |||||
Lawton IADL Scale | X | |||||
CD-RISC-10 | X | |||||
Medical record review | X | |||||
Hospital readmissions | X | |||||
ICU readmissions | X | |||||
Emergency department visits | X | |||||
Rehabilitation services/psychological therapy | X | |||||
30 s & 60 s Sit-to-Stand Test | X | |||||
Medication reconciliation/ number of concurrent medications | X | |||||
Focus group | X |
*Intervention group only.
ADLs, activities of daily living; CD-RISC-10, 10-item Connor-Davidson Resiliency Scale; CFS, Clinical Frailty Scale; CPGS, Chronic Pain Grade Scale; FSS, Fatigue Severity Scale; HADS, Hospital Anxiety and Depression Scale to evaluate anxiety and depression; HUI3, Health Utilities Index Mark 3 for health-related quality of life assessment; IADLs, instrumental activities of daily living; MoCA, Montreal Cognitive Assessment for neurocognitive function; PTSS-14, Post-Traumatic Stress Symptoms-14 to evaluate for post-traumatic stress disorder symptoms; SF-36, 36-item Short Form Health Survey for quality-of-life assessment.